Home Tools
Log in
Cart

Search Result

Search Results for " bioavailable "

Targets

538

Compounds

7

Natural Products

Cat No. Product Name Synonyms Targets
T9497 Niraparib tosylate monohyrate PARP
Niraparib, also know as MK-4827, is an inhibitor of poly (ADP-ribose) polymerase (PARP) with potential antineoplastic activity. MK4827 inhibits PARP activity, enhancing the accumulation of DNA strand breaks and promoting...
T39695 ARD-2128 Androgen Receptor
ARD-2128 is a highly potent, orally bioavailable PROTAC (proteolysis-targeting chimera) degrader of the androgen receptor (AR), effectively diminishing AR protein levels, suppressing AR-regulated gene expression in tumor...
T12266 Ilginatinib NS-018 Tyrosine Kinases , JAK
Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.
T5414 Glumetinib SCC244 c-Met/HGFR
Glumetinib (SCC244) (SCC 244) is a novel potent and selective inhibitor of c-Met kinase (IC50: 0.42 nM).
T12266L2 Ilginatinib hydrochloride NS-018 hydrochloride Tyrosine Kinases , JAK
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2.
T12266L Ilginatinib maleate NS-018 maleate Tyrosine Kinases , JAK
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2.
T4488 GSK-25 GSK25 ROCK , S6 Kinase , mTOR
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
T3231 Niraparib MK-4827 Apoptosis , Others , PARP
Niraparib (MK-4827) is a PARP inhibitor that selectively inhibits PARP1 and PARP2 (IC50=3.8/2.1 nM). Niraparib has antitumor activity, inhibits DNA damage repair, and induces apoptosis.
T6714 URB-597 KDS-4103,FAAH Inhibitor II Mitophagy , FAAH , Autophagy
URB-597 (FAAH Inhibitor II) is an effective, orally bioavailable FAAH inhibitor (IC50: 4.6 nM), and no effect on other cannabinoid-related targets.
T6041 Oprozomib PR-047,ONX 0912 Proteasome , Autophagy
Oprozomib (PR-047) (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome β5(IC50=36 nM)/LMP7(IC50=82 nM), is orally bioavailable. Oprozomib also has potential antineoplastic activity.
T2119 Venetoclax GDC-0199,ABT 199,ABT-199,ABT199 BCL , Autophagy
Venetoclax (ABT-199) is a Bcl-2 inhibitor (Ki<0.01 nM) with potent, selective, and orally active properties. Venetoclax has a 3-order-of-magnitude lower affinity for Bcl-xL and Bcl-W (Kis=48/245 nM). Venetoclax induces a...
T17225 Vercirnon CCX282-B,GSK-1605786,Traficet-EN CCR
Vercirnon (Traficet-EN) is a selective and potent antagonist of CCR9 (IC50: 10 nM). It is also used in the research of inflammatory bowel diseases.
T9146 Ms48107 Benzenemethanol, 2-[4-amino-6-[[(4-phenoxyphenyl)methyl]amino]-1,3,5-triazin-2-yl]-3-fluoro- Others
MS48107 is a potent, selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68), demonstrating specificity for GPR68 over closely related proton GPCRs, neurotransmitter transporters, and hERG ion ch...
T3353 Niraparib hydrochloride MK-4827 hydrochloride,MK-4827 (hydrochloride) Apoptosis , Others , PARP
Niraparib hydrochloride (MK-4827 hydrochloride) is an inhibitor of poly (ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Niraparib hydrochloride inhibits PARP activity, enhancing the accumulation of...
T6892 Niraparib tosylate MK-4827 (tosylate),MK 4827 tosylate,Niraparib (MK-4827) tosylate Apoptosis , PARP
Niraparib tosylate (MK-4827 (tosylate))(with IC50 of 3.8 nM/2.1 nM) is a selective PARP1/PARP2 inhibitor.
T26174 SAK3 SAK-3,SAK 3
SAK 3 is a potent and orally bioavailable CaV3.1/3.3 activator.
T15198 Edasalonexent CAT-1004 NF-κB
Edasalonexent is an orally bioavailable inhibitor of NF-κB.
T39573 GSK251 PI3K
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
T17218 Varespladib methyl A-002,LY333013 Others , Phospholipase
Varespladib methyl (LY333013), a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
T10300 AMG2850 TRP/TRPV Channel
AMG2850 is a potent, orally bioavailable, and selective antagonist of transient receptor potential melastatin 8 (TRPM8).
T11226 ERK1/2 inhibitor 1 ERK
ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively.
T12847 SB-616234-A SB-616234A 5-HT Receptor
SB-616234A is a selective and orally bioavailable antagonist of 5-HT1B receptor, with anxiolytic and antidepressant activity.
T2351 Fasiglifam TAK875 GPR
Fasiglifam (TAK875) is a potent, selective and orally bioavailable GPR40 agonist.
TQ0029 ASTX660 IAP
ASTX660 is an orally bioavailable dual antagonist of cIAP and XIAP.
T3389 Antitumor agent-21 TRX818 Others
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
T5417 INCB-057643 Apoptosis , Epigenetic Reader Domain
INCB057643 is a potent, selective and orally bioavailable BET inhibitor.
T4510 Polaprezinc Zinc L-carnosine Others
Polaprezinc is an bioavailable chelate comprised of zinc and L-carnosine, known for its gastrointestinal protective properties, as well as its anti-ulcer, antioxidant, and anti-inflammatory effects.
T16776 RO9021 Syk
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).
TQ0069 MI-503 Epigenetic Reader Domain , Histone Methyltransferase
MI-503 is a highly effective and orally bioavailable inhibitor of the menin-mLL interaction.
T17179 Tulrampator CX-1632,S-47445 iGluR
Tulrampator (S-47445) is an orally bioavailable positive AMPAR with antidepressant effects.
T20454 4-Chlorophenylurea NSC12971,NSC 12971,NSC-12971 Factor Xa
4-Chlorophenylurea (NSC-12971) is a novel orally bioavailable inhibitor of factor Xa.
T14901 CCT-251921 CDK
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
T6123 Verdinexor KPT-335 CRM1
Verdinexor (KPT-335) (KPT-335), a specific XPO1/CRM1 inhibitor, are orally bioavailable.
T3544 SHP099 hydrochloride Phosphatase , Others
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
T2360 Baricitinib phosphate Baricitinib Phosphate,LY3009104,INCB-028050 phosphate,LY-3009104 phosphate,INCB028050 Tyrosine Kinases , JAK
Baricitinib phosphate (INCB028050) is a selective orally bioavailable JAK1/JAK2 inhibitor.
T6692 TAK-733 TAK733,TAK 733 MEK
TAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
T4490 PF-01247324 Sodium Channel
PF-01247324 is a selective and orally bioavailable Nav1.8 channel blocker (IC50: 196 nM).
T12395 PDE9-IN-1 PDE
PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM).
T2259 Silmitasertib CX-4945 Casein Kinase , Autophagy
Silmitasertib (CX-4945) is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
TQ0229 ETP-46321 PI3K
ETP-46321 is an effective and orally bioavailable PI3Kα/PI3Kδ inhibitor (Ki: 2.3/14.2 nM).
T6965 RG7112 RG-7112,RG 7112,RO5045337 Mdm2 , E1/E2/E3 Enzyme
RG7112 (RO5045337) (RO5045337) is an orally bioavailable and selective p53-MDM2 inhibitor.
T6101 Entospletinib GS-9973 Syk
Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable.
T6053 Turofexorate Isopropyl XL335,FXR-450,WAY-362450 FXR , Autophagy
Turofexorate Isopropyl (XL335) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM
T10929L D-3263 hydrochloride EC D-3263 HCl,D3263 HCl salt TRP/TRPV Channel
D-3263 hydrochloride (D3263 HCl salt) is enteric-coated, orally bioavailable transient receptor potential melatonin member 8 (TRPM8) agonist.
T7667 R1487 p38 MAPK
R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.
T12431 PF-06882961 Glucagon Receptor
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
T6117 Tivantinib ARQ 197 Apoptosis , c-Met/HGFR
Tivantinib (ARQ 197) is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
T5555 Siremadlin NVP-HDM 201 E1/E2/E3 Enzyme
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor.
T1961 Vistusertib AZD2014 Apoptosis , Akt , PI3K , S6 Kinase , mTOR , Autophagy
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
T11444 GNF-6231 Porcupine
GNF-6231 is a potent, selective, and orally bioavailable Porcupine inhibitor that blocks Wnt signaling.

Compounds

Niraparib tosylate monohyrate
T9497
Synonym:
Target: PARP
ARD-2128
T39695
Synonym:
Target: Androgen Receptor
Ilginatinib
T12266
Synonym: NS-018
Target: Tyrosine Kinases, JAK
Glumetinib
T5414
Synonym: SCC244
Target: c-Met/HGFR
Ilginatinib hydrochloride
T12266L2
Synonym: NS-018 hydrochloride
Target: Tyrosine Kinases, JAK
Ilginatinib maleate
T12266L
Synonym: NS-018 maleate
Target: Tyrosine Kinases, JAK
GSK-25
T4488
Synonym: GSK25
Target: ROCK, S6 Kinase, mTOR
Niraparib
T3231
Synonym: MK-4827
Target: Apoptosis, Others, PARP
URB-597
T6714
Synonym: KDS-4103,FAAH Inhibitor II
Target: Mitophagy, FAAH, Autophagy
Oprozomib
T6041
Synonym: PR-047,ONX 0912
Target: Proteasome, Autophagy
Venetoclax
T2119
Synonym: GDC-0199,ABT 199,ABT-199,ABT199
Target: BCL, Autophagy
Vercirnon
T17225
Synonym: CCX282-B,GSK-1605786,Traficet-EN
Target: CCR
ms48107
T9146
Synonym: Benzenemethanol, 2-[4-amino-6-[[(4-phenoxyphenyl)methyl]amino]-1,3,5-triazin-2-yl]-3-fluoro-
Target: Others
Niraparib hydrochloride
T3353
Synonym: MK-4827 hydrochloride,MK-4827 (hydrochloride)
Target: Apoptosis, Others, PARP
Niraparib tosylate
T6892
Synonym: MK-4827 (tosylate),MK 4827 tosylate,Niraparib (MK-4827) tosylate
Target: Apoptosis, PARP
SAK3
T26174
Synonym: SAK-3,SAK 3
Target:
Edasalonexent
T15198
Synonym: CAT-1004
Target: NF-κB
GSK251
T39573
Synonym:
Target: PI3K
Varespladib methyl
T17218
Synonym: A-002,LY333013
Target: Others, Phospholipase
AMG2850
T10300
Synonym:
Target: TRP/TRPV Channel
ERK1/2 inhibitor 1
T11226
Synonym:
Target: ERK
SB-616234-A
T12847
Synonym: SB-616234A
Target: 5-HT Receptor
Fasiglifam
T2351
Synonym: TAK875
Target: GPR
ASTX660
TQ0029
Synonym:
Target: IAP
Antitumor agent-21
T3389
Synonym: TRX818
Target: Others
INCB-057643
T5417
Synonym:
Target: Apoptosis, Epigenetic Reader Domain
Polaprezinc
T4510
Synonym: Zinc L-carnosine
Target: Others
RO9021
T16776
Synonym:
Target: Syk
MI-503
TQ0069
Synonym:
Target: Epigenetic Reader Domain, Histone Methyltransferase
Tulrampator
T17179
Synonym: CX-1632,S-47445
Target: iGluR
4-Chlorophenylurea
T20454
Synonym: NSC12971,NSC 12971,NSC-12971
Target: Factor Xa
CCT-251921
T14901
Synonym:
Target: CDK
Verdinexor
T6123
Synonym: KPT-335
Target: CRM1
SHP099 hydrochloride
T3544
Synonym:
Target: Phosphatase, Others
Baricitinib phosphate
T2360
Synonym: Baricitinib Phosphate,LY3009104,INCB-028050 phosphate,LY-3009104 phosphate,INCB028050
Target: Tyrosine Kinases, JAK
TAK-733
T6692
Synonym: TAK733,TAK 733
Target: MEK
PF-01247324
T4490
Synonym:
Target: Sodium Channel
PDE9-IN-1
T12395
Synonym:
Target: PDE
Silmitasertib
T2259
Synonym: CX-4945
Target: Casein Kinase, Autophagy
ETP-46321
TQ0229
Synonym:
Target: PI3K
RG7112
T6965
Synonym: RG-7112,RG 7112,RO5045337
Target: Mdm2, E1/E2/E3 Enzyme
Entospletinib
T6101
Synonym: GS-9973
Target: Syk
Turofexorate Isopropyl
T6053
Synonym: XL335,FXR-450,WAY-362450
Target: FXR, Autophagy
D-3263 hydrochloride
T10929L
Synonym: EC D-3263 HCl,D3263 HCl salt
Target: TRP/TRPV Channel
R1487
T7667
Synonym:
Target: p38 MAPK
PF-06882961
T12431
Synonym:
Target: Glucagon Receptor
Tivantinib
T6117
Synonym: ARQ 197
Target: Apoptosis, c-Met/HGFR
Siremadlin
T5555
Synonym: NVP-HDM 201
Target: E1/E2/E3 Enzyme
Vistusertib
T1961
Synonym: AZD2014
Target: Apoptosis, Akt, PI3K, S6 Kinase, mTOR, Autophagy
GNF-6231
T11444
Synonym:
Target: Porcupine
1 2 3 4 5 6 7 8 9 10 11
Cat No. Product Name Synonyms Targets
T2807 Caffeic Acid Lipoxygenase , Endogenous Metabolite , TRP/TRPV Channel
Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
T13092 Tauro-Obeticholic acid FXR
Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
T5041 Faropenem sodium Antibacterial , Antibiotic
Faropenem sodium is an orally bioavailable penem antibiotic which can efficiently kill Mycobacterium tuberculosis.It treatment of tuberculosis and community-acquired pneumonia.
T5113 L-GLUCOSE L-(-)-Glucose Others
L-Glucose (L-(-)-Glucose) is an enantiomer of D-glucose. L-Glucose is not bioavailable to cells as an energy source because it cannot be phosphorylated by hexokinase.
T6674 L-Ascorbic acid sodium salt (+)-Sodium L-ascorbate,Vitamin C sodium salt,Sodium ascorbate,L-Ascorbic acid sodium,Sodium L-ascorbate Apoptosis , Others , Calcium Channel , Reactive Oxygen Species , Endogenous Metabolite
L-Ascorbic acid sodium salt (Vitamin C sodium salt) is a more bioavailable form of vitamin C that is an alternative to taking ascorbic acid as a supplement.
T2220 2-Methoxyestradiol NSC-659853,2-MeOE2,2-ME2 Apoptosis , Reactive Oxygen Species , Microtubule Associated , Endogenous Metabolite , HIF , Autophagy
2-Methoxyestradiol (2-ME2) is an orally bioavailable estradiol metabolite with potential antineoplastic activity. 2-Methoxyestradiol inhibits angiogenesis by reducing endothelial cell proliferation and inducing endotheli...
T6491 (-)-(S)-Equol (−)-Equol,Equol,4',7-Dihydroxyisoflavan,4',7-Isoflavandiol Estrogen Receptor/ERR , Estrogen/progestogen Receptor , Endogenous Metabolite
(-)-(S)-Equol (4',7-Dihydroxyisoflavan) is an orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with potential chemoprotective a...
TargetMol